Search details
1.
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
N Engl J Med
; 383(24): 2320-2332, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-32877576
Results
1 -
1
de 1
1
Next >
>>